Quantcast

Case activity for Kristy Marken vs Coopersurgical Inc. on Oct. 13

PENNSYLVANIA RECORD

Sunday, December 22, 2024

Case activity for Kristy Marken vs Coopersurgical Inc. on Oct. 13

Filings
General court 10

shutterstock.com

The U.S. District Court for the Eastern District of Pennsylvania reported the following activities in the suit brought by Kristy Marken against Coopersurgical Inc., Duramed Pharmaceuticals Inc. a Division of Barr Pharmaceuticals, INC., D B a Teva Women's Health, INC., THE Cooper Companies Inc., Teva Pharmaceuticals USA Inc., Teva Women's Health Inc., Individually, and, Teva Women's Health LLC F K a Teva Women's Health, Inc. and Teva Women's Health LLC, Individually and on Oct. 13.

'Notice Of Removal By The Cooper Companies, Inc, Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc., D/b/a Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., Coopersurgical, Inc., Teva Pharmaceuticals Usa, Inc, Teva Women's Health, Llc F/k/a Teva Women's Health, Inc. (filing Fee $ 400 Receipt Number 0313-14632537), Filed By The Cooper Companies, Inc, Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc., D/b/a Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., Coopersurgical, Inc., Teva Pharmaceuticals Usa, Inc, Teva Women's Health, Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Vanguard Group, Inc. By The Cooper Companies, Inc.(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including The Cooper Companies, Inc. By Coopersurgical, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Pharmaceuticals Usa, Inc.(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Women's Health, Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

'Answer To Complaint By Teva Pharmaceuticals Usa, Inc.(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health, Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

Case number 2:20-cv-05059-HB was filed in the U.S. District Court for the Eastern District of Pennsylvania on Oct. 13.

More News